Progress
RAQuantity
24794
Category
Tab Tegafur 20mg Gimeracil 5 poing 8mg plus Oteraci
Bid Type
Two Packet Bid
The Indian Army, Department Of Military Affairs, seeks pharmaceutical supplies in Ambala, Haryana (133001) with an estimated value of ₹382,139. The tender covers a wide product category listing 22 medical and drug items, including oncology and supportive therapies, with stringent documentation and compliance prerequisites. A core differentiator is the inclusion of the option clause allowing up to 25% quantity variation at contracted rates and a strict shelf-life policy. The procurement emphasizes OEM authorization, barcoding via Dhanwantari software, and mandatory invoice submission at delivery. This indicates a highly regulated, hospital-centered supply chain requiring traceability and serial alignment with government software. The packaging and delivery must align to the hospital’s reception standards, with a focus on authenticity and regulatory compliance.
Product category: pharmaceutical/medicinal tablets and related items (22 items listed in BOQ)
Quantity: Not specified in BOQ; exact items and counts to be provided by bidder
Standards/Certifications: OEM authorization certificates required; barcode generation via Dhanwantari software
Shelf Life: Indian origin ≥ 56% of total shelf life; imported origin ≥ 23% of total shelf life
Delivery & Invoicing: Purchase invoices to be produced at delivery
Barcoding: All delivered goods must be barcoded in Dhanwantari software
Option Clause: 25% quantity variation allowed during contract, with proportional delivery extension
Option Clause allows up to 25% quantity increase/decrease at contracted rates
Shelf life criteria must be met: Indian origin ≥ 56%, imported ≥ 23%
OEM authorization and Dhanwantari barcode compliance are mandatory
Purchase invoices must accompany delivery; barcodes required on all items
Not explicitly stated in tender data; verify in official terms
Delivery period as per order; option clause allows extended duration based on quantity changes
Not detailed in provided data; check terms for LDs or penalties on non-compliance
Must provide OEM authorization for all quoted medicines
Must be able to supply 22 listed items with compliant packaging and barcoding
Must register and demonstrate Dhanwantari software usage for barcodes
Tender Category
Goods
Bid To RA
No
Bid To RA Enabled
Yes
Item Category
Tab Tegafur 20mg Gimeracil 5 poing 8mg plus Oteraci , Tab Temozolamide 100 mg , Tab Tamoxifen 20 mg , Tab Sorafenib 200 mg , Tab Relugolix 120mg , Tab Pomalidomide 4 mg , Tab Nintedanib 150 mg , Tab Nintedanib 100 mg , Tab Mexiletene 150 mg , Tab Magesterol 160mg , Tab Letrozole 2 point 5 mg , Tab Lenvatinib 4mg , Tab Lenalidomide 5 mg , Tab Hydroxy Urea 500mg , Tab Gefitinib 250 mg , Tab Erlotinib 150 mg , Tab Dasatinib 50 mg , Tab Capacetabin 500 mg , Tab Cabozatinib 40 mg , Tab Bicalutamide 50mg , Tab Anastrazole 1 mg , Tab Nitisinone 5 mg
End-to-end support — bid preparation, GeM registration, document filing & compliance by industry experts.
Free consultation · 24h response
Main Document
BOQ
BOQ
OTHER
GEM_GENERAL_TERMS_AND_CONDITIONS
Tab Tegafur 20mg Gimeracil 5 poing 8mg plus Oteraci
Tab Tegafur 20mg Gimeracil 5 poing 8mg plus Oteracil
Tab Temozolamide 100 mg
Tab Temozolamide 100 mg
Tab Tamoxifen 20 mg
Tab Tamoxifen 20 mg
Tab Sorafenib 200 mg
Tab Sorafenib 200 mg
Tab Relugolix 120mg
Tab Relugolix 120mg
Tab Pomalidomide 4 mg
Tab Pomalidomide 4 mg
Tab Nintedanib 150 mg
Tab Nintedanib 150 mg
Tab Nintedanib 100 mg
Tab Nintedanib 100 mg
Tab Mexiletene 150 mg
Tab Mexiletene 150 mg
Tab Magesterol 160mg
Tab Magesterol 160mg
Tab Letrozole 2 point 5 mg
Tab Letrozole 2 point 5 mg
Tab Lenvatinib 4mg
Tab Lenvatinib 4mg
Tab Lenalidomide 5 mg
Tab Lenalidomide 5 mg
Tab Hydroxy Urea 500mg
Tab Hydroxy Urea 500mg
Tab Gefitinib 250 mg
Tab Gefitinib 250 mg
Tab Erlotinib 150 mg
Tab Erlotinib 150 mg
Tab Dasatinib 50 mg
Tab Dasatinib 50 mg
Tab Capacetabin 500 mg
Tab Capacetabin 500 mg
Tab Cabozatinib 40 mg
Tab Cabozatinib 40 mg
Tab Bicalutamide 50mg
Tab Bicalutamide 50mg
Tab Anastrazole 1 mg
Tab Anastrazole 1 mg
Tab Nitisinone 5 mg
Tab Nitisinone 5 mg
| Item # | Title | Description | Quantity | Unit | Consignee | Delivery (Days) | Price Trends |
|---|---|---|---|---|---|---|---|
| 1 | Tab Tegafur 20mg Gimeracil 5 poing 8mg plus Oteraci | Tab Tegafur 20mg Gimeracil 5 poing 8mg plus Oteracil | 252 | no | mslp2@mh123 | 30 | |
| 2 | Tab Temozolamide 100 mg | Tab Temozolamide 100 mg | 75 | no | mslp2@mh123 | 30 | |
| 3 | Tab Tamoxifen 20 mg | Tab Tamoxifen 20 mg | 2,000 | no | mslp2@mh123 | 30 | |
| 4 | Tab Sorafenib 200 mg | Tab Sorafenib 200 mg | 270 | no | mslp2@mh123 | 30 | |
| 5 | Tab Relugolix 120mg | Tab Relugolix 120mg | 180 | no | mslp2@mh123 | 30 | |
| 6 | Tab Pomalidomide 4 mg | Tab Pomalidomide 4 mg | 147 | no | mslp2@mh123 | 30 | |
| 7 | Tab Nintedanib 150 mg | Tab Nintedanib 150 mg | 1,620 | no | mslp2@mh123 | 30 | |
| 8 | Tab Nintedanib 100 mg | Tab Nintedanib 100 mg | 780 | no | mslp2@mh123 | 30 | |
| 9 | Tab Mexiletene 150 mg | Tab Mexiletene 150 mg | 360 | no | mslp2@mh123 | 30 | |
| 10 | Tab Magesterol 160mg | Tab Magesterol 160mg | 2,000 | no | mslp2@mh123 | 30 | |
| 11 | Tab Letrozole 2 point 5 mg | Tab Letrozole 2 point 5 mg | 4,000 | no | mslp2@mh123 | 30 | |
| 12 | Tab Lenvatinib 4mg | Tab Lenvatinib 4mg | 750 | no | mslp2@mh123 | 30 | |
| 13 | Tab Lenalidomide 5 mg | Tab Lenalidomide 5 mg | 1,050 | no | mslp2@mh123 | 30 | |
| 14 | Tab Hydroxy Urea 500mg | Tab Hydroxy Urea 500mg | 600 | no | mslp2@mh123 | 30 | |
| 15 | Tab Gefitinib 250 mg | Tab Gefitinib 250 mg | 650 | no | mslp2@mh123 | 30 | |
| 16 | Tab Erlotinib 150 mg | Tab Erlotinib 150 mg | 270 | no | mslp2@mh123 | 30 | |
| 17 | Tab Dasatinib 50 mg | Tab Dasatinib 50 mg | 1,320 | no | mslp2@mh123 | 30 | |
| 18 | Tab Capacetabin 500 mg | Tab Capacetabin 500 mg | 1,400 | no | mslp2@mh123 | 30 | |
| 19 | Tab Cabozatinib 40 mg | Tab Cabozatinib 40 mg | 360 | no | mslp2@mh123 | 30 | |
| 20 | Tab Bicalutamide 50mg | Tab Bicalutamide 50mg | 2,600 | no | mslp2@mh123 | 30 | |
| 21 | Tab Anastrazole 1 mg | Tab Anastrazole 1 mg | 3,990 | no | mslp2@mh123 | 30 | |
| 22 | Tab Nitisinone 5 mg | Tab Nitisinone 5 mg | 120 | no | mslp2@mh123 | 30 |
GST registration certificate
PAN card
Experience certificates for pharmaceutical supply (if applicable)
Financial statements or turnover documents
EMD documents (amount to be confirmed in Terms)
OEM authorization certificates for all quoted products
Technical bid documents detailing product specifications
Dhanwantari software registration proof
Barcoding compliance documents for hospital delivery
Purchase invoices or vendor invoices for prior similar supply
Start
27-Feb-2026, 3:00 pm
End
28-Feb-2026, 3:00 pm
Duration: 24 hours
Reverse Auction Document
✅ RA concluded. Check financial results for final rankings.
| S.No | Seller | Item | Date | Status |
|---|---|---|---|---|
| 1 | ********** Under PMA | - | 14-02-2026 12:10:17 | |
| 2 | ********** Under PMA | - | 11-02-2026 15:14:32 | |
| 3 | ********** Under PMA | - | 14-02-2026 11:10:58 | |
| 4 | ********** Under PMA | - | 13-02-2026 19:38:15 | |
| 5 | ********** Under PMA | - | 11-02-2026 14:15:13 | |
| 6 | ********** Under PMA | - | 13-02-2026 18:42:31 | |
| 7 | ********** Under PMA | - | 13-02-2026 20:32:21 | |
| 8 | ********** Under PMA | - | 14-02-2026 12:52:57 | |
| 9 | ********** Under PMA | - | 14-02-2026 16:49:05 | |
| 10 | ********** Under PMA | - | 13-02-2026 17:05:20 | |
| 11 | ********** Under PMA | - | 14-02-2026 16:38:08 | |
| 12 | ********** Under PMA | - | 13-02-2026 13:08:01 | |
| 13 | ********** Under PMA | - | 05-02-2026 19:14:06 | |
| 14 | ********** Under PMA | - | 12-02-2026 13:03:46 | |
| 15 | ********** Under PMA | - | 14-02-2026 12:33:54 | |
| 16 | ********** Under PMA | - | 14-02-2026 15:05:27 | |
| 17 | ********** Under PMA | - | 09-02-2026 11:11:52 | |
| 18 | ********** Under PMA | - | 13-02-2026 12:44:28 | |
| 19 | ********** Under PMA | - | 13-02-2026 16:35:55 | |
| 20 | ********** Under PMA | - | 11-02-2026 18:52:23 | |
| 21 | ********** Under PMA | - | 13-02-2026 17:33:47 |
Key insights about HARYANA tender market
Bidders must submit OEM authorization certificates for all quoted medicines, register on the Dhanwantari software, and provide barcoded packaging. Ensure shelf life criteria are met (56% for Indian origin, 23% for imported). Include purchase invoices at delivery and complete GST/PAN documentation.
Required documents include GST registration, PAN, OEM authorizations for each item, financial statements, experience certificates, Dhanwantari registration proof, and purchase invoices for delivered items. Also provide barcoding compliance evidence and shelf-life certification for Indian/imported products.
For Indian-origin products, remaining shelf life must be at least 56% of total shelf life; for imported-origin products, at least 23% of total shelf life. Items not meeting criteria will be rejected and disqualified from technical evaluation.
The purchaser may increase or decrease order quantity up to 25% at bid quantity, with proportional delivery time calculated as (additional quantity ÷ original quantity) × original delivery period, minimum 30 days, and no extension beyond remaining scope.
Delivery must be accompanied by the purchase invoice at the time of delivery. All items must be barcoded via the Dhanwantari software, and the supplier must demonstrate packaging and traceability as per hospital standards.
Mandatory OEM authorization for each product; barcoding through Dhanwantari software; registration proof for the software; shelf-life compliance as per origin; ensure all items meet hospital procurement standards.
Barcoding is mandatory; failure to provide Dhanwantari-generated barcodes will lead to technical disqualification. Ensure all 22 items are properly registered and scannable at delivery.
Estimated value is ₹382,139 for 22 listed items. The BOQ lists 22 drugs, but exact quantities per item are not specified publicly; bidders must supply detailed itemwise quantities with tender response.
Sign up now to access all documents
Main Document
BOQ
BOQ
OTHER
GEM_GENERAL_TERMS_AND_CONDITIONS